Seok‐Beom Yong

Korea Research Institute of Bioscience and Biotechnology — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index580citations21works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(7), Immune cells in cancer(6), CAR-T cell therapy research(4), Immunotherapy and Immune Responses(3), Adipokines, Inflammation, and Metabolic Diseases(2)

Publications21 total

CRISPRa Lipid Nanocomplex‐Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid‐β in an Alzheimer's Disease Mouse Model
Advanced Science·2025Open Access
Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates
Biomedicine & Pharmacotherapy·2025· 5 citedOpen Access
Microbiome Metabolite-Incorporated Lipid Nanoparticles Augment CD8<sup>+</sup> T Cell Memory Potential and Immunity for mRNA Cancer Vaccines
ACS Biomaterials Science & Engineering·2025· 3 cited
Dual Adjuvant‐Loaded Peptide Antigen Self‐Assembly Potentiates Dendritic Cell‐Mediated Tumor Immunotherapy
Advanced Science·2024· 13 citedOpen Access
Microbiome-Derived Lipid Nanoparticles for Improved Immunogenicity of mRNA Vaccines
ACS Materials Letters·2024· 4 cited
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery (Adv. Sci. 19/2023)
Advanced Science·2023Open Access
A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
Advanced Science·2023· 90 citedOpen Access
Engineering TGF-β inhibitor-encapsulated macrophage-inspired multi-functional nanoparticles for combination cancer immunotherapy
Biomaterials Research·2023· 24 citedOpen Access
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer (Adv. Mater. 13/2022)
Advanced Materials·2022· 3 cited
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Advanced Materials·2022· 61 citedOpen Access
White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes
Biomaterials·2021· 43 cited
Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia
Advanced Science·2020· 32 citedOpen Access
CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells
Biomaterials·2019· 17 cited
Targeted delivery of CRISPR interference system against <i>Fabp4</i> to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
Genome Research·2019· 87 citedOpen Access
Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
Biomaterials·2019· 80 cited
Correction to: Recent challenges and advances in genetically-engineered cell therapy
Journal of Pharmaceutical Investigation·2018Open Access
Recent challenges and advances in genetically-engineered cell therapy
Journal of Pharmaceutical Investigation·2017· 29 citedOpen Access
Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes
Biomaterials·2017· 33 cited
Human monocyte-targeted non-viral siRNA delivery for the suppression of inflammatory macrophages
Journal of Controlled Release·2017
Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation
Scientific Reports·2017· 10 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Yong‐Hee Kim(12), Jee Young Chung(8), Yoonsung Song(7), Gonna Somu Naidu(4), Srinivas Ramishetti(4), Assaf Ezra(4), Meir Goldsmith(4), Inbal Hazan‐Halevy(4), Sushmita Chatterjee(4), Dan Peer(3), Jaehyun Kim(3), Riccardo Rampado(2), Preeti Sharma(2), Anjaiah Aitha(2), Qurrat Ul Ain(2), Sehee Ra(2), Yael Diesendruck(2), Hyung Jin Kim(2), Juhyeong Hong(2), Hyungjin Kim(2)